Abstract
Purpose
We previously reported that all-trans retinoic acid (ATRA) inhibited growth in human T-cell leukemia virus type I (HTLV-I)-positive T-cell lines and in fresh cells from patients with adult T cell leukemia (ATL). Here, we confirmed the clinical effects of ATRA in 20 patients with ATL.
Materials and methods
The 20 patients (n = 20) with a median age of 56 (range 35–73) years who were diagnosed with ATL received ATRA orally.
Results
The efficacy of treatment was as follows: no complete response (CR), a partial response (PR) in 40% of the patients, no change (NC) in 45% of the patients, and a progressive disease (PD) in 15% of the patients. In seven acute-type ATL patients, a PR was achieved in two (28.5%), NC was observed in two (28.5%), and a PD was observed in three (42.8%). In three lymphoma-type ATL patients, a PR (100%) was achieved. Among four chronic-type ATL patients, a PR was achieved in one (25%) and NC was observed in the remaining three (75%). In six smoldering-type ATL patients, a PR was achieved in two (33.3%) and NC was observed in four (66.6%). The major side effects were headache (n = 5), transient liver dysfunction (n = 2), hyperlipidemia (n = 2), and anorexia (n = 1).
Conclusion
These results indicated that ATRA might be a useful agent for the safe treatment of ATL.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Altucci L, Gronemeyer H (2001) The promise of retinoids to fight against cancer. Nat Rev Cancer 1:181–193
Bazarbachi A, Hermine O (2001) Treatment of adult T cell leukemia/lymphoma: current strategy and future perspectives. Virus Res 78:79–92
Borg A, Yin JA, Johnson PR, Tosswill J, Saunders M, Morris D (1996) Successful treatment of HTLV-I-associated acute adult T-cell leukemia lymphoma by allogeneic bone marrow transplantation. Br J Haematol 94:713–715
Evans TR, Kaye SB (1999) Retinoids: present role and future potential. Br J Cancer 80:1–8
Guidoboni M, Zancai P, Cariati R, Rizzo S, Dal Col J, Pavan A et al (2005) Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma. Cancer Res 65:587–595
Hermine O, Wattel E, Gessain A, Bazarbachi A (1998) Adult T-cell leukemia: a review of established and new treatments. Bio Drugs 10:447–462
Hinuma Y, Nagata K, Hanaoka M, Nakai M, Matsumoto T, Kinoshita K, Shirakawa S, Miyoshi I (1981) Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 78:6476–6480
Ljungman P, Lawler M, Asjo B, Bogdanovic G, Karlsson K, Malm C et al (1994) Infection of donor lymphocytes with human T-lymphotrophic virus type I (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukemia. Br J Haematol 88:403–405
Lotan R (1980) Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 605:33–91
Maeda Y, Miyatake J-I, Sono H, Sumimoto Y, Matsuda M, Horiuchi F et al (1996) New therapeutic effects of retinoid for adult T cell leukemia. Blood 88:4726–4727
Maeda Y, Naiki Y, Sono H, Miyatake J-I, Sumimoto Y, Sakaguchi M, Matsuda M, Kanamaru A (2000) Clinical application of all-trans retinoic acid (Tretinoin) for adult T cell leukemia. Br J Haematol 109:677–678
Maeda Y, Yamaguchi T, Ueda S, Miyazato H, Matsuda M, Kanamaru A (2004) All-trans retinoic acid reduced skin involvement of adult T-cell leukemia. Leukemia 18:1159–1160
Miyatake J-I, Maeda Y (1997) Inhibition of proliferation and CD25 down-regulation by retinoic acid in human adult T cell leukemia cells. Leukemia 11:401–407
Miyatake J-I, Maeda Y, Nawata H, Naiki Y, Sumimoto Y, Matsuda M, Kanamaru A (2000) Important role of thiol compounds to protect oxidative stress on HTLV-I (+) T lymphocytes. Leuk Res 24:265–266
Nawata H, Maeda Y, Sumimoto Y, Miyatake J-I, Kanamaru A (2001) A mechanism of apoptosis induced by all-trans retinoic acid on adult T-cell leukemia cells: a possible involvement of the Tax/NF-kappaB signaling pathway. Leuk Res 25:323–331
Rio B, Louvet C, Gessain A, Dormont D, Gisselbrecht C, Matoia R et al (1990) Adult T-cell leukemia and non-malignant adenopathies associated with HTLV-I virus. Apropos of 17 patients born in the Caribbean region and Africa. Presse Med 19:746–751
Shimoyama M (1992) Treatment of patients with adult T-cell leukemia-lymphoma: an overview. In: advances in adult T-cell leukemia and HTLV-I research. Scientific Societies Press, Tokyo, 39:43–56
Smith MA, Parkinson DR, Cheson BD, Friedman MA (1992) Retinoids in cancer therapy. J Clin Oncol 10:839–864
Sobue R, Yamauchim T, Miyamura K, Sao H, Tahara T, Yoshikawa H et al (1987) Treatment of adult T cell leukemia with mega-dose cyclophosphamide and total body irradiation followed by allogeneic bone marrow transplantation. Bone Marrow Transplant 2:441–444
Sumimoto Y, Maeda Y, Naiki Y, Sono H, Miyatake J-I, Sakaguchi M, Matsuda M, Kanamaru A (2000) Establishment of a myeloid cell line, YM711, characterized by retinoid resistance. Leuk Lymphoma 39:373–383
Taguchi H, Kinoshita KI, Takatsuki K, Tomonaga M, Araki K, Arima N et al (1996) An intensive chemotherapy of adult T-cell leukemia/Lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. J Acquir Immune Defic Syndr Hum Retrovirol 12:182–189
Toshima M, Nagai T, Izumi T, Tarumoto T, Takatoku M, Imagawa S, Komatsu M, Ozawa K (2000) All-trans-retinoic acid treatment for chemotherapy-resistant acute adult T-cell leukemia. Int J Hematol 72:343–345
Trump DL (1994) Retinoid in bladder, testis and prostate cancer: epidemiologic, pre-clinical and clinical observations. Leukemia 8:50–54
Tsukasaki K, Fujimoto T, Hata T, Yamada Y, Kamihira S, Tomonaga M (1995) Concomitant complete remission of APL and smoldering ATL following ATRA therapy in a patient with the two diseases simultaneously. Leukemia 9:1797–1978
Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H (1977) Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 50:481–492
Yamada Y, Tomonaga M, Fukuda H, Nanada S, Utsunomia A, Tara M et al (2001) A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia–lymphoma: Japan clinical oncology group study 9303. Br J Haematol 113:375–382
Yamaguchi T, Maeda Y, Ueda S, Hijikata Y, Morita Y, Miyatake JI, Matsuda M, Kanamaru A (2005) Dichotomy of all-trans retinoic acid inducing signals for adult T-cell leukemia. Leukemia 19:1010–1017
Acknowledgments
The authors thank Mrs. K. Furukawa and Mrs. K. Niki for their technical support and Ms. S. Nagayama and Ms. S. Yoshida for preparing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maeda, Y., Yamaguchi, T., Hijikata, Y. et al. Clinical efficacy of all-trans retinoic acid for treating adult T cell leukemia. J Cancer Res Clin Oncol 134, 673–677 (2008). https://doi.org/10.1007/s00432-007-0334-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-007-0334-6